TriSalus Life Sciences, Inc.
SEC 4 · Filed
0001628280-26-020186Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Mar 17, 2026
- Security
- Common Stock
- Shares
-
15,944
- Price per share
-
3.85
Structured facts
{
"code": "S",
"date": "2026-03-17",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."
},
"owners": [
{
"cik": "0001410289",
"name": "Szela Mary T",
"roles": [
"director",
"officer"
],
"title": "CEO and President"
}
],
"ownership": "D",
"post_shares": "752987",
"price": "3.85",
"row": 2,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "15944",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}Insider transactionsEvent date Mar 11, 2026
- Security
- Common Stock
- Shares
-
4,358
- Price per share
-
4.13
Structured facts
{
"code": "S",
"date": "2026-03-11",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."
},
"owners": [
{
"cik": "0001410289",
"name": "Szela Mary T",
"roles": [
"director",
"officer"
],
"title": "CEO and President"
}
],
"ownership": "D",
"post_shares": "768931",
"price": "4.13",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "4358",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}